News
Gene TherapiesR&D project spotlight: Towards continuous manufacturing for high-dose, cost-efficient rAAV therapies
CGT Catapult leads industry consortium developing universal test to increase the safety and efficiency of stem cell therapiesCGT Catapult to take part in consortium aiming to improve the sustainability of CAR-T manufacturingRegulatory Round-up - November 2025CGT Catapult annual review highlights the role of advanced therapies in supporting Government ambitions for public health and economic growthRegulatory Round-up - October 2025CGT Catapult awarded two Princess Royal Training Awards for its skills and training programmesNew evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economyUnderstanding life with Beta ThalassemiaCGT Catapult and Autolomous showcase benefits of digital technologies in advanced therapy manufacturingRegulatory Round-up - September 2025R&D project spotlight: Deciphering rAAV production dynamics in HEK293 clones through multi-omics profilingCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vessels
